Clodronate and Liposome‐Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′‐(β,γ‐Dichloromethylene) Triphosphate, by Mammalian Cells In Vitro

Clodronate, alendronate, and other bisphosphonates are widely used in the treatment of bone diseases characterized by excessive osteoclastic bone resorption. The exact mechanisms of action of bisphosphonates have not been identified but may involve a toxic effect on mature osteoclasts due to the induction of apoptosis. Clodronate encapsulated in liposomes is also toxic to macrophages in vivo and may therefore be of use in the treatment of inflammatory diseases. It is generally believed that bisphosphonates are not metabolized. However, we have found that mammalian cells in vitro (murine J774 macrophage‐like cells and human MG63 osteosarcoma cells) can metabolize clodronate (dichloromethylenebisphosphonate) to a nonhydrolyzable adenosine triphosphate (ATP) analog, adenosine 5′‐(β,γ‐dichloromethylene) triphosphate, which could be detected in cell extracts by using fast protein liquid chromatography. J774 cells could also metabolize liposome‐encapsulated clodronate to the same ATP analog. Liposome‐encapsulated adenosine 5′‐(β,γ‐dichloromethylene) triphosphate was more potent than liposome‐encapsulated clodronate at reducing the viability of cultures of J774 cells and caused both necrotic and apoptotic cell death. Neither alendronate nor liposome‐encapsulated alendronate were metabolized. These results demonstrate that the toxic effect of clodronate on J774 macrophages, and probably on osteoclasts, is due to the metabolism of clodronate to a nonhydrolyzable ATP analog. Alendronate appears to act by a different mechanism.

[1]  P. Reitsma,et al.  APD in Paget's disease of bone. Role of the mononuclear phagocyte system? , 1980, Arthritis and rheumatism.

[2]  A. Urtti,et al.  Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. , 1994, Journal of drug targeting.

[3]  T. Martin,et al.  Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. , 1993, The Journal of clinical investigation.

[4]  S. Miller,et al.  The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat , 1979, The Anatomical record.

[5]  P. Reitsma,et al.  Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. , 1982, The Journal of clinical investigation.

[6]  B. Uitdehaag,et al.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.

[7]  M. Williamson,et al.  Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum. , 1992, Biochemical and biophysical research communications.

[8]  C. Bortner,et al.  The role of DNA fragmentation in apoptosis. , 1995, Trends in cell biology.

[9]  T. Yoneda,et al.  Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  N. Van Rooijen Liposome-mediated elimination of macrophages. , 1992, Research in immunology.

[11]  G. Klein,et al.  Methylenediphosphonate, a metabolic poison in Dictyostelium discoideum. Phosphorus-31 NMR evidence for accumulation of adenosine 5'-(.beta.,.gamma.-methylenetriphosphate) and diadenosine 5',5'''-P1,P4-(P2,P3-methylenetetraphosphate) , 1988 .

[12]  G. Blackburn,et al.  The synthesis and metal binding characteristics of novel, isopolar phosphonate analogues of nucleotides , 1984 .

[13]  H. Fleisch,et al.  The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. , 1978, The Biochemical journal.

[14]  K. Goa,et al.  Clodronate , 1994, Drugs.

[15]  M. Satre,et al.  Cytotoxicity of dichloromethane diphosphonate and of 1-hydroxyethane-1,1-diphosphonate in the amoebae of the slime mould Dictyostelium discoideum. A 31P NMR study. , 1992, Biochemical pharmacology.

[16]  J. Kanis,et al.  Comparison of three intravenous regimens of clodronate in paget disease of bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  M. Williamson,et al.  Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. , 1994, The Biochemical journal.

[18]  G. Rodan,et al.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. , 1991, The Journal of clinical investigation.

[19]  R. Russell,et al.  DIPHOSPHONATES AND PAGET'S DISEASE OF BONE , 1971 .

[20]  H. Fleisch,et al.  Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo , 1969, Science.

[21]  T. Chambers,et al.  Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. , 1989, Bone and mineral.

[22]  M. Cecchini,et al.  Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[24]  A. Douglas-Jones,et al.  The effect of free and liposome‐encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat , 1995, Clinical and experimental immunology.

[25]  P. Boonekamp,et al.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. , 1986, Bone and mineral.

[26]  F. Emmrich,et al.  Apoptotic cell death in activated monocytes following incorporation of clodronate‐liposomes , 1996, Journal of leukocyte biology.

[27]  G. Blackburn,et al.  Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. , 1996, Biochemical and biophysical research communications.

[28]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[29]  M. Rogers,et al.  Mechanisms of Action of Bisphosphonates as Inhibitors of Bone Resorption , 1996 .

[30]  Gowen,et al.  Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. , 1989, The Journal of clinical investigation.

[31]  K. Savolainen,et al.  Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro. , 1996, The Journal of pharmacology and experimental therapeutics.

[32]  C. Löwik,et al.  Interleukin‐6 and the acute phase response during treatment of patients with paget's disease with the nitrogen‐containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  A. D. Geddes Bisphosphonates : Structure-Activity Relationships and Therapeutic Implications , 1994 .

[34]  R. Dodds,et al.  Microcytophotometric analysis of human osteoclast metabolism: lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  H. Fleisch,et al.  Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo , 1969, Science.

[36]  G. Rodan,et al.  Bisphosphonates: mechanisms of action , 1998, Endocrine reviews.

[37]  F. Emmrich,et al.  Treatment of rat arthritides with clodronate-containing liposomes. , 1995, Scandinavian journal of rheumatology. Supplement.

[38]  F. Emmrich,et al.  Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. , 1995, Arthritis and rheumatism.

[39]  P. Schlesinger,et al.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. , 1990, The Journal of clinical investigation.

[40]  D. Thiebaud,et al.  Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. , 1996, Bone.

[41]  J. Kanis,et al.  Consequences of neoplasia induced bone-resorption and the use of clodronate (review). , 1994, International journal of oncology.

[42]  J. Lawry,et al.  Bisphosphonates induce apoptosis in mouse macrophage‐like cells in vitro by a nitric oxide‐independent mechanism , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  F. H. Ebetino,et al.  Cellular uptake of bisphosphonates: Localisation using fluorescently- labelled alendronate , 1995 .

[44]  H. Fleisch Bisphosphonates , 2012, Drugs.

[45]  N. Kugai,et al.  Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. , 1996, Bone.